Who owns the data in clinical trial?

Area of Science:

• Medical research
• Data science
• Bioinformatics

Background:

• Investigator-generated data are crucial for testing scientific hypotheses.
• Clinical datasets, particularly those concerning disease biology and treatment, often contain sensitive medical information.
• The ownership of clinical data is a significant consideration due to sponsor interest in research outcomes.

Purpose of the Study:

• To advocate for the open availability of scientific research data.
• To address the critical issue of data ownership in hypothesis-driven research.
• To propose a framework for responsible data sharing.

Main Methods:

• The study is based on the author's opinion and expert judgment regarding data accessibility.
• It emphasizes the need for data formats that ensure confidentiality and protect intellectual property.
• The author suggests a timeframe for data release post-publication.

Main Results:

• The author posits that data from both public and private research funding should be shared.
• Confidentiality and intellectual property rights must be preserved in data dissemination.
• Access should be granted to responsible parties within a reasonable period after study publication.

Conclusions:

• Open access to scientific data, including clinical data, is essential for scientific advancement.
• A balance must be struck between data sharing, patient privacy, and intellectual property protection.
• Timely data availability promotes further research and validation.